Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

318 ARTÍCULOS , VIENDO DEL 61 AL 75

Effects of multimodal nondrug therapy on dementia symptoms and need for care in nursing home residents with degenerative dementia: a randomized-controlled study with 6-month follow-up

Luttenberger K, Donath C, Uter W, Graessel E.

J Am Geriatr Soc. 2012 May;60(5):830-40. doi: 10.1111/j.1532-5415.2012.03938.x. Epub 2012 Apr 3.

Engineered antibody approaches for Alzheimer's disease immunotherapy

Robert R, Wark KL.

Arch Biochem Biophys. 2012 Oct 15;526(2):132-8. doi: 10.1016/j.abb.2012.02.022. Epub 2012 Mar 27.

Integrating cytosolic phospholipase A₂ with oxidative/nitrosative signaling pathways in neurons: a novel therapeutic strategy for AD

Sun GY, He Y, Chuang DY, Lee JC, Gu Z, Simonyi A, Sun AY.

Mol Neurobiol. 2012 Aug;46(1):85-95. doi: 10.1007/s12035-012-8261-1. Epub 2012 Apr 3.

Pharmacoeconomics of Alzheimer's disease (AD) treatment with cholinesterase inhibitors

Versijpt J.

Acta Neurol Belg. 2012 Jun;112(2):141-5. doi: 10.1007/s13760-012-0062-9. Epub 2012 Apr 4.

Editorial: Anti Alzheimer agents

Hugel H.

Mini Rev Med Chem. 2012 May;12(5):363. doi: 10.2174/138955712800493889.

A controlled clinical trial on the effects of exercise on neuropsychiatric disorders and instrumental activities in women with Alzheimer's disease

Nascimento CM, Teixeira CV, Gobbi LT, Gobbi S, Stella F.

Rev Bras Fisioter. 2012 Jun;16(3):197-204. doi: 10.1590/s1413-35552012005000017. Epub 2012 Apr 12.

Recruitment, retention and other methodological issues related to clinical trials for Alzheimer's disease

Vellas B.

J Nutr Health Aging. 2012 Apr;16(4):330. doi: 10.1007/s12603-012-0043-y.

Recruitment strategies for preventive trials. The MAPT study (MultiDomain Alzheimer Preventive Trial)

Carrié I, van Kan GA, Gillette-Guyonnet S, Andrieu S, Dartigues JF, Touchon J, Dantoine T, Rouaud O, Bonnefoy M, Robert P, Cuffi MN, Bories L, Bordes S, Gasnier Y, Desclaux F, Sudres K, Pesce A, Vellas B.

J Nutr Health Aging. 2012 Apr;16(4):355-9. doi: 10.1007/s12603-012-0046-8.

Persons with Alzheimer's disease make phone calls independently using a computer-aided telephone system

Perilli V, Lancioni GE, Singh NN, O'Reilly MF, Sigafoos J, Cassano G, Cordiano N, Pinto K, Minervini MG, Oliva D.

Res Dev Disabil. 2012 Jul-Aug;33(4):1014-20. doi: 10.1016/j.ridd.2012.01.007. Epub 2012 Feb 21.

Small-molecule BACE1 inhibitors: a patent literature review (2006 - 2011)

Probst G, Xu YZ.

Expert Opin Ther Pat. 2012 May;22(5):511-40. doi: 10.1517/13543776.2012.681302. Epub 2012 Apr 19.

Possible usefulness of growth hormone/insulin-like growth factor-I axis in Alzheimer's disease treatment

Sáez JM.

Endocr Metab Immune Disord Drug Targets. 2012 Sep;12(3):274-86. doi: 10.2174/187153012802002857.

Cotinine: a potential new therapeutic agent against Alzheimer's disease

Echeverria V, Zeitlin R.

CNS Neurosci Ther. 2012 Jul;18(7):517-23. doi: 10.1111/j.1755-5949.2012.00317.x. Epub 2012 Apr 25.

[Intended pharmacotherapeutical approaches of Alzheimer's disease therapy]

Korábecný J, Hrubá E, Soukup O, Zemek F, Musílek K, Nepovímová E, Spilovská K, Opletalová V, Kuca K.

Ceska Slov Farm. 2012 Feb;61(1-2):4-10.

The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model

Bond M, Rogers G, Peters J, Anderson R, Hoyle M, Miners A, Moxham T, Davis S, Thokala P, Wailoo A, Jeffreys M, Hyde C.

Health Technol Assess. 2012;16(21):1-470. doi: 10.3310/hta16210.

Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study

Vedin I, Cederholm T, Freund-Levi Y, Basun H, Garlind A, Irving GF, Eriksdotter-Jönhagen M, Wahlund LO, Dahlman I, Palmblad J.

PLoS One. 2012;7(4):e35425. doi: 10.1371/journal.pone.0035425. Epub 2012 Apr 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias